in the global healthcare arena and Ranbaxy endeavors to be at the forefront in delivering the India centric advantages to the advanced and developing countries of the world. From a small domestic company at inception‚ Ranbaxy has grown formidably to be a Billion dollar institution that was envisioned by Late Dr Parvinder Singh‚ Chairman and Managing Director‚ Ranbaxy in early 90’s. It is with the unwavering ’ dedication ’ and the ’ will to win ’ of Team Ranbaxy across the globe that it has traversed
Premium Human resource management
Ranbaxy Laboratories Ltd. (RLL) is the largest pharmaceutical company incorporated in India. It is also amongst the top league globally and is ranked 9th largest generic company worldwide. Ranbaxy is also credited with the tag of true Indian multinational. The company traces its roots to a chemist shop in Delhi. It is one of the first Indian pharmaceutical company to start a joint venture abroad. Rapid growth of Ranbaxy is attributed mainly to its focused research and joint ventures in India and
Premium Generic drug Marketing Ranbaxy Laboratories
| Ranbaxy Laboratories Ltd. | | "Personally‚ I feel that companies who constantly innovate to provide better products and services and who can offer superior value propositions to the consumer are the ones likely to command more respect globally than others” Malvinder Mohan Singh‚ former CEO and MD‚ Ranbaxy Laboratories Ltd Table of Contents Executive Summary 5 The Company 5 Hybrid Business Model 6 Porter’s Five Force Analysis 7 Bargaining Power of Buyers 8 Bargaining
Premium Generic drug Pharmaceutical industry Ranbaxy Laboratories
Ranbaxy – Daiichi Sankyo Deal Akash Bangani Dipika Bhura Gaurav Khetan Neetu Rathod 12065 12077 12082 12118 Agenda • • • • • • • • • • Industry Overview Companies’ Profiles Snapshot of the deal Financing the deal Benefits to Daiichi Benefits to Ranbaxy Synergies Post Acquisition challenges Recent Developments Conclusion Indian Pharmaceutical Industry • Present size of $14 billion. • Ranks 4th in world in terms of production and 13th in terms of consumption. • Highly fragmented. 325 large
Premium Generic drug Pharmaceutical industry 3rd millennium
9 9.1 9.2 10 11 Title Introduction Background of Ranbaxy Brief History Market share of Ranbaxy Background of Daiichi Sankyo Brief History Market share of Daiichi Sankyo SPOT Analysis of the Indian Pharma Industry Resaons for the Deal Why Ranbaxy did it Why Daiichi Sankyo did it Disadvantages of the deal The Deal Shareholding Pattern Interpretation of the Shareholding pattern Financing the Deal Effects of the Acquisition Benefits for Ranbaxy Benefits for Daiichi Sankyo Benefits for the combined
Premium Pharmaceutical industry Generic drug
to the Daiiichi - Ranbaxy acquisition RANBAXY LABORATORIES LIMITED Ranbaxy Laboratories Limited‚ India’s largest pharmaceutical company‚ was an integrated‚ research based‚ international pharmaceutical company producing a wide range of quality‚ affordable generic medicines‚ trusted by healthcare professionals and patients across geographies. It was incorporated in 1961 by Singh’s grandfather Bhai Mohan Singh‚ further his son Dr. Parvinder Singh succeeded it‚ transforming Ranbaxy into India’s first
Premium Generic drug Ranbaxy Laboratories
Individually-prepared case analysis of a two case‚ which will be selected by students from among those done in class. Students can select the cases of their choice‚ as suits their schedule and interest area(s). Case analyses will be handed-in at the beginning of class. The case write-up should be no more than ten pages (double-spaced‚ 12-point Arial font) in length‚ with a maximum of seven exhibits. The student should write the case assignment from the perspective of the main character in the
Premium Question Typeface Character
Summary This case explores the possibility of a brand extension for Revital‚ the bestselling vitamin and mineral supplement and number-one nutraceutical brand in India and a top Ranbaxy Global Consumer Healthcare product. The case examines Revital’s shift from a prescription product to a popular over-the-counter (OTC) brand and explores Ranbaxy’s strategies to position Revital as the brand with the highest recall. It assesses Revital’s competitors in India’s booming nutraceutical market in a scenario
Free Target market Marketing Caffeine
1. What impresses you about Norton Lilly International? What has accounted for Norton Lilly’s success over the past 150+ years? What aspects of Norton Lilly do you find unimpressive? Norton Lilly is a company that has showcased its ability to withstand the test of time. The company has steadily grow and expanded both nationally and internationally since getting their start in 1841. The company was able to shift with the tides when cargo containerization came into the fold in the 1970. The ability
Premium Strategic management Management
Financial Analysis Eli Lilly & Company 2013 Annual Report Group Group 22 Ibrahim Ibrahim Al-Oraifi Al-Oraifi Dheya Dheya Al-Shehabiyah Al-Shehabiyah Namir Namir Al-Bassam Al-Bassam Happy Happy New New Year‚ Year‚ 2015 2015 Company Confidential © 2013 Eli Lilly and Company INTRODUCTION Founded in1876 by Col. Eli Lilly Headquarters in Indianapolis‚ Indiana The first company to mass-produce penicillin The world’s largest manufacturer and distributor of psychiatric medications • Products marketed
Premium Balance sheet Cash flow Income statement